Approval for Listing; No Suspension. The Placement Shares shall have either been (i) approved for listing, subject to notice of issuance, on the Nasdaq, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq at or prior to the issuance of the Placement Notice. Trading in the Common Shares shall not have been suspended on the Nasdaq or the TASE.
Appears in 5 contracts
Samples: At the Market Offering Agreement (Oramed Pharmaceuticals Inc.), Controlled Equity Offering Agreement (Oramed Pharmaceuticals Inc.), Equity Distribution Agreement (Oramed Pharmaceuticals Inc.)
Approval for Listing; No Suspension. The Placement Shares shall have either been (i) approved for listing, subject to notice of issuance, on the NasdaqThe Nasdaq Global Market, or (ii) the Company shall have filed an application for listing of the Placement Shares on the The Nasdaq Global Market at or prior to the issuance of the Placement NoticeNotice and Nasdaq shall not have raised any objection thereto. Trading in the Common Shares shall not have been suspended on the The Nasdaq or the TASEGlobal Market.
Appears in 2 contracts
Samples: Equity Distribution Agreement (T2 Biosystems, Inc.), Equity Distribution Agreement (T2 Biosystems, Inc.)
Approval for Listing; No Suspension. The Placement Shares shall have either been (i) approved for listing, subject to notice of issuance, on the Nasdaq, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq at or prior to the issuance of the Placement Notice. Trading in the Common Shares shall not have been suspended on the Nasdaq or the TASENasdaq.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Clene Inc.), Equity Distribution Agreement (Obalon Therapeutics Inc)
Approval for Listing; No Suspension. The Placement Shares shall have either been (i) approved for listing, subject to notice of issuance, on Nasdaq and the NasdaqTSX-V, or (ii) the Company shall have filed an application for listing of the Placement Shares on Nasdaq and the Nasdaq TSX-V at or prior to the issuance of the Placement Notice. Trading in the Common Shares shall not have been suspended on the Nasdaq or the TASEsuch market.
Appears in 2 contracts
Samples: Equity Distribution Agreement (HIVE Digital Technologies Ltd.), Equity Distribution Agreement (HIVE Digital Technologies Ltd.)
Approval for Listing; No Suspension. The Placement Shares shall have either been (i) approved for listing, subject to notice of issuance, on the Nasdaq, or (ii) the Company shall have filed an application for listing of the Placement Shares on the Nasdaq at or prior to the issuance of the Placement Notice. Trading in the Common Shares Stock shall not have been suspended on the Nasdaq or the TASENasdaq.
Appears in 1 contract
Samples: Equity Distribution Agreement (5E Advanced Materials, Inc.)
Approval for Listing; No Suspension. The Placement Shares shall have either been (i) approved for listing, subject to notice of issuance, on the NasdaqNasdaq and the TSX, or (ii) the Company Corporation shall have filed an application for listing of the Placement Shares on the Nasdaq and the TSX at or prior to the issuance of the Placement Notice. Trading in the Common Shares shall not have been suspended on the Nasdaq or the TASEsuch markets.
Appears in 1 contract
